Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000891836-05-000176
Filing Date
2005-03-09
Accepted
2005-03-09 17:29:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc0087.htm SC 13G 17438
  Complete submission text file 0000891836-05-000176.txt   18905
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Subject) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48323 | Film No.: 05670254
SIC: 2834 Pharmaceutical Preparations

Mailing Address NARRAGANSETT MANAGEMENT, LP 540 MADISON AVENUE, 38TH FLOOR NEW YORK NY 10022
Business Address 212.813.5855
Dowling Joseph L III (Filed by) CIK: 0001297011 (see all company filings)

Type: SC 13G